ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,900Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 1155

$579K Total Retail Price of All Prescriptions

Rank: 21 out of 1155

593 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 593 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

13% of this provider’s 593 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 10,099 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
SIMVASTATIN 706 640 1 3
ATORVASTATIN CALCIUM 421 385 2 12
METFORMIN HCL 404 340 3 7
LISINOPRIL 388 344 4 1
LEVOTHYROXINE SODIUM 364 329 5 2
ATENOLOL 306 274 6 10
HYDROCODONE-ACETAMINOPHEN 297 214 S3 7 4
AMLODIPINE BESYLATE 287 279 8 6
GABAPENTIN 232 147 9 15
TAMSULOSIN HCL 209 179 10 27
OMEPRAZOLE 197 123 11 5
ALLOPURINOL 196 181 12 29
METOPROLOL TARTRATE 192 177 13 14
FUROSEMIDE 180 171 14 8
HYDROCHLOROTHIAZIDE 180 167 14 9
LOSARTAN POTASSIUM 152 142 16 18
TRAZODONE HCL 140 113 17 22
ZOLPIDEM TARTRATE 126 102 18 21
METOPROLOL SUCCINATE 121 121 19 17
FLUTICASONE PROPIONATE 118 103 20 37
LOVASTATIN 116 116 21 13
GLYBURIDE 115 99 R 22 75
POTASSIUM CHLORIDE 114 108 23 16
LOSARTAN-HYDROCHLOROTHIAZIDE 114 105 23 65
TRIAMTERENE-HCTZ 112 97 25 51
FLUOXETINE HCL 110 97 26 30
CITALOPRAM HBR 108 93 27 19
ALENDRONATE SODIUM 106 106 28 25
ADVAIR DISKUS 99 96 29 35
SERTRALINE HCL 98 86 30 24
MELOXICAM 94 61 31 52
WARFARIN SODIUM 85 85 32 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 67 33 26
CLOPIDOGREL 80 80 34 70
FINASTERIDE 80 80 34 104
CYCLOBENZAPRINE HCL 79 44 R 36 38
PROAIR HFA 79 41 36 31
PLAVIX 76 63 38 115
OXYBUTYNIN CHLORIDE 75 75 39 71
PREMARIN 75 75 R 39 110
NAMENDA 74 74 41 67
TRAMADOL HCL 74 57 41 32
GLIMEPIRIDE 73 61 43 43
ACTONEL 71 59 44 163
FENTANYL 66 18 S2 45 64
CARVEDILOL 65 64 46 28
PRAVASTATIN SODIUM 62 62 47 20
PANTOPRAZOLE SODIUM 61 61 48 47
OXYCONTIN 60 49 S2 49 80
EVISTA 59 57 50 157
BISOPROLOL-HYDROCHLOROTHIAZIDE 58 58 51 144
RANITIDINE HCL 56 44 52 33
AVODART 55 50 53 209
OXYCODONE HCL 53 47 S2 54 23
VENLAFAXINE HCL ER 51 49 55 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 24, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.